These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6785798)

  • 1. Use of the intracerebral injection technique to elucidate mechanisms of apomorphine climbing and its antagonism in the mouse.
    Costall B; Naylor RJ; Nohria V
    Psychopharmacology (Berl); 1981; 73(1):91-4. PubMed ID: 6785798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mesolimbic system, denervation and the climbing response in the mouse.
    Costall B; Fortune DH; Naylor RJ; Nohria V
    Eur J Pharmacol; 1980 Aug; 66(2-3):207-15. PubMed ID: 6108225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine antagonist properties of atypical neuroleptics may be revealed following mesolimbic denervation.
    Nohria V; Costall B; Naylor RJ
    Int Pharmacopsychiatry; 1981; 16(1):21-9. PubMed ID: 6117535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour.
    Costall B; Eniojukan JF; Naylor RJ
    Eur J Pharmacol; 1983 Dec; 96(3-4):201-10. PubMed ID: 6426976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat climbing behavior elicited by stimulation of cerebral dopamine receptors.
    Protais P; Bonnet JJ; Costentin J; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):93-101. PubMed ID: 6425703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine agonist action in mesolimbic, cortical and extrapyramidal areas to modify spontaneous climbing behaviour of the mouse.
    Costall B; Eniojukan JF; Naylor RJ
    Psychopharmacology (Berl); 1985; 86(4):452-7. PubMed ID: 3929317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity.
    Costall B; Naylor RJ; Nohria V
    Eur J Pharmacol; 1978 Jul; 50(1):39-50. PubMed ID: 28233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of serotonergic activity in nucleus accumbens septi on drug-induced circling.
    Jackson EA; Kelly PH; Schultz L
    Neuropharmacology; 1985 Aug; 24(8):721-7. PubMed ID: 3939326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of neostriatum and nucleus accumbens in stepping induced by apomorphine and dexamphetamine.
    Cools AR; Jongen-Relo AL
    Brain Res Bull; 1991 Jun; 26(6):909-17. PubMed ID: 1933411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microwave facilitation of domperidone antagonism of apomorphine-induced stereotypic climbing in mice.
    Quock RM; Kouchich FJ; Ishii TK; Lange DG
    Bioelectromagnetics; 1987; 8(1):45-55. PubMed ID: 3579999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses.
    Herrera-Marschitz M; Casas M; Ungerstedt U
    Psychopharmacology (Berl); 1988; 94(1):38-45. PubMed ID: 3126526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of fluphenazine-N-mustard on dopamine binding sites and on behavior induced by apomorphine in supersensitive mice.
    Thermos K; Winkler JD; Weiss B
    Neuropharmacology; 1987 Oct; 26(10):1473-80. PubMed ID: 3120028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of infusions of 6-hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat.
    Winn P; Robbins TW
    Neuropharmacology; 1985 Jan; 24(1):25-31. PubMed ID: 3920545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum.
    Protais P; Costentin J; Schwartz JC
    Psychopharmacology (Berl); 1976 Oct; 50(1):1-6. PubMed ID: 827755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of injections of 6-OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug-induced activity.
    Joyce EM; Stinus L; Iversen SD
    Neuropharmacology; 1983 Sep; 22(9):1141-5. PubMed ID: 6415508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
    Davis A; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1990; 100(1):19-26. PubMed ID: 1967499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supersensitivity to apomorphine in experimentally induced hypokinesia and drug-induced modifications of the apomorphine response.
    Voith K
    Psychopharmacology (Berl); 1980; 70(3):247-54. PubMed ID: 6777797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narcotic analgesics and stereotyped behaviour in mice.
    Langwiński R; Niedzielski J
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul; 312(3):225-7. PubMed ID: 6105624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.